Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
Domo Inc. (NASDAQ: DOMO) Chief Financial Officer Tod Crane sold 68,483 shares of Class B Common Stock on June 24, 2026, to satisfy tax obligations from Restricted Stock Unit vesting. The transaction occurred at a weighted average price of $2.3776 per share, leaving Crane with 276,809 directly owned shares. The sale takes place against a backdrop of…
Domo Inc. Founder and CEO Joshua James executed a transaction to dispose of 96,088 shares of Class B Common Stock on June 24, 2026, generating proceeds of $228,458. The sale, priced at a weighted average of $2.3776 per share, was structured to satisfy tax obligations related to the vesting and settlement of Restricted Stock Units. Following the tra…
Matteo Arduini, President of Hydraulics and FCT at Helios Technologies Inc. (NASDAQ: HLIO), executed a series of stock dispositions totaling approximately $904,681 between June 22 and June 23, 2026. The sales come as the company's shares trade near their 52-week high of $92.41, following a period of substantial appreciation. Prior to the sales, Ard…
Michael Kornelsen, serving as a director at Lifeloc Technologies, Inc. (NASDAQ:LCTC), has executed a recent transaction to acquire additional shares of the company's common stock. This purchase, formalized through a Form 4 filing submitted to the Securities and Exchange Commission, provides a direct snapshot of insider activity within the enterpris…
Michael Alexander Smith, Insmed Inc.'s chief legal officer, executed a $173,050 sale of 1,806 shares on June 22, 2026, under a pre-arranged 10b5-1 plan. The sale occurs as the company navigates a period of executive restructuring and shifting analyst sentiment regarding its financial outlook and valuation.
Joseph Nelson, serving as Principal Financial Officer, Principal Accounting Officer, and Treasurer at Carlyle Credit Income Fund (NASDAQ: CCIF), executed a share purchase on June 22, 2026. The transaction involved 2,000 shares at $2.73 each, bringing Nelson’s direct holdings to 5,700 shares. The buy occurs as the fund’s stock trades close to its 52…
Immuneering Corp (NASDAQ:IMRX) President and CEO Benjamin J. Zeskind has purchased an additional 2,400 shares of the company's Class A Common Stock, bringing his total direct holdings to 2,315,252 shares. The acquisition, valued at $10,948, was executed on June 23, 2026, with shares purchased at prices ranging from $4.55 to $4.59. This transaction …
Thomas Edwards Jr., Macy’s Executive Vice President, Chief Operating Officer, and Chief Financial Officer, sold 16,419 shares of the company’s common stock on June 24, 2026, for a total value of $408,726. The transaction was a non-discretionary sale executed specifically to cover tax withholding obligations related to the vesting of restricted stoc…
Mallun Yen, a director at Everpure, Inc. (NASDAQ:P), executed a significant reduction in her equity position, selling 4,735 shares of Class A Common Stock on June 22, 2026. The transaction, valued at approximately $364,121, took place at prices ranging from $76.83 to $76.97 per share. This sale follows a period of robust financial performance for t…
Omada Health (NASDAQ:OMDA) Chief Financial Officer Steven L. Cook executed a sale of 17,950 shares of common stock on June 22, 2026, valued at $325,394. The transaction, conducted under a 10b5-1 trading plan adopted in March 2026, occurred at prices ranging from $18.00 to $18.30 per share, with a weighted average of $18.1278. Following the sale, Co…
Jacob R. Petkovich, President of Marine operations at Patrick Industries Inc. (NASDAQ: PATK), executed a share purchase totaling $124,246 on May 6, 2026. The transaction involved acquiring 1,300 shares at a weighted average price of $95.5745, with individual prices ranging from $95.47 to $95.64. This acquisition brings his direct ownership to 46,29…
Serge Saxonov, Chief Executive Officer of 10x Genomics, Inc. (NASDAQ:TXG), executed a sale of 29,900 shares of Class A Common Stock on June 22, 2026, valued at approximately $1,033,268. The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 29, 2025. Following these sales, Saxonov directly holds 1,108,380 …
Kayne Anderson Energy Infrastructure Fund, Inc. (NYSE:KYN) director Michael J. Hennigan has executed a series of direct stock purchases totaling $271,600. The transactions span two days in late June 2026, bringing his direct ownership stake to 20,000 shares. The insider activity occurs as the fund continues its long-standing dividend policy and tra…
Jonathan Mead Beaulier, Snowflake Inc.'s Chief Revenue Officer, executed a significant stock transaction on June 22, 2026, selling over $2.17 million worth of company shares. This move comes as Snowflake navigates a complex market environment, with analysts highlighting both its growth potential and valuation concerns. Concurrently, competitor Data…
McBee Brannin, serving as the Chief Development Officer for CoreWeave, Inc. (NASDAQ: CRWV), executed a transaction involving the sale of 500 shares of the company's Class A Common Stock on June 22, 2026. The transaction, valued at $55,632, occurred within a price range of $107.05 to $119.00 per share. These sales were facilitated under a Rule 10b5-…
Nicholas A. Saccomano, President and CEO of OnKure Therapeutics, Inc. (NASDAQ: OKUR), executed a routine sale of 86 shares to satisfy tax withholding requirements tied to the vesting of restricted stock units (RSUs). This transaction, valued at $378, aligns with standard practices under the company's 2023 RSU Equity Incentive Plan. Concurrently, On…
Eric L. Oliver, a significant ten percent owner of Cross Timbers Royalty Trust (NASDAQ:CRT), alongside affiliated entities SoftVest, LP and SoftVest GP I, LLC, has executed a series of purchases totaling $481,666 in beneficial interest units. The acquisitions, completed on June 22 and June 23, 2026, bring the total indirect holdings of SoftVest, LP…
Disc Medicine, Inc. (NASDAQ: IRON) Chief Operating Officer Jonathan Yen-Wen Yu executed a significant transaction involving the sale of 9,700 shares of the company's common stock on June 22, 2026. The sale, valued at $704,795, occurred at prices between $72.50 and $72.68 per share, which is slightly above the stock's closing price of $70.37. This a…
Oncotelic Therapeutics, Inc. (OTLC) Chairman and Chief Executive Officer Trieu Vuong has executed a series of open market purchases, increasing his direct ownership stake in the company. The insider activity occurs as the biotechnology firm announces a strategic collaboration with TechForce Robotics, Inc. to integrate advanced robotics hardware wit…
Nicholas S. Schorsch and a group of affiliated entities, all identified as ten-percent owners of American Strategic Investment Co. (NASDAQ: NYC), have executed a series of purchases totaling approximately $28,335 in the company's Class A common stock. The transactions, filed via SEC Form 4, occurred between June 22 and June 24, 2026, with shares ac…
Kevin Prehn, serving as Concorde Division President at Universal Technical Institute Inc. (NASDAQ:UTI), executed a sale of 4,545 shares of the company's common stock on June 22, 2026. The transaction, valued at $181,800 based on a $40.00 share price, highlights ongoing executive activity within the education and training sector. This divestment occ…
Melinda D. Whittington, President and CEO of La-Z-Boy Incorporated (NASDAQ:LZB), executed a series of share sales totaling approximately $1.36 million in late June 2026. These transactions, conducted under a Rule 10b5-1 trading plan established in February 2026, involved the liquidation of shares acquired through option exercises. The sales occur a…
Quantum-Si Inc. (NASDAQ:QSI) Chief Financial Officer Jeffry Keyes completed the sale of company shares totaling $7,641 on June 22 and June 23, 2026. These transactions were executed under a mandatory sell-to-cover provision designed to satisfy federal, state, and local withholding taxes associated with the vesting of restricted stock units. The CFO…
Jean Francois Formela, a director at Korro Bio, Inc. (NASDAQ:KRRO), has executed the sale of approximately $2.46 million worth of common stock over a three-day period in late June 2026. The transactions, which involved the disposition of 171,405 shares, were conducted under a Rule 10b5-1 trading plan adopted earlier in the year. The shares were hel…
John Zahurancik, serving as Senior Vice President and Chief Commercial and Strategy Officer at Fluence Energy, Inc. (NASDAQ:FLNC), recently executed two separate sales of company stock on June 22 and June 23, 2026. These transactions resulted in the disposal of approximately $754,702 worth of Class A Common Stock. The sales occurred against a backd…
